The independent source for health policy research, polling, and news.
1,741-1,760 of 1,942 results
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent âunapprovedâ and âmisbrandedâ drugs to U.S. consumers, jeopardizing their safety.
New research shows how an experience with surprise medical bills can guide patientsâ future decision-making.
A proposed state law with bipartisan, bicameral support is on the move in Texas. It would force hospitals and insurers to settle surprise bills â instead of relying on patients to start the mediation process. The KHN/NPR "Bill of the Month" series is a catalyst for the effort.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program âWashington Journal,â where she fielded viewersâ calls about high drug prices and industry criticism.
In a new poll, consumers give thumbs up to ads that display drug prices and the removal of barriers to generics, among other cost-cutting measures.
The progressive proposal adds details to the discussion of this controversial approach to overhauling the nationâs health system, and Democratic primary candidates will have to be prepared to get more specific.
An animal lover stopped to feed a hungry-looking stray cat outside Everglades National Park in Florida. First, the cat bit her finger â then the hospital billed her close to $50,000 for a treatment that typically costs about $3,000.
Carol Marley has pancreatic cancer â and dealing with its financial toll has become her full-time job.
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Tuesdayâs Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
The stateâs governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nationâs drug-pricing problem.
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
Tuesdayâs Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
The Centers for Medicare & Medicaid Services launched this month the âWhatâs Coveredâ app, designed to provide yes-or-no answers about what services are covered under traditional Medicare. KHN took it for a test drive with real consumers.
Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHNâs Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.
Health officials and doctors treating patients with HIV welcome the funding push, but warn that the strategies that work in progressive cities don't necessarily translate to rural areas.
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue thatâs not medically necessary to pay for.
© 2026 51ÊÓÆ”